Key facts
- Fermecutes’s last known valuation is $6.1M (Jul 2025).
- It has raised $1.7M; the latest was Seed Round ($1.7M) in Jul 2025.
- Notable investors include Intellectual Property Acceleration Program for Startups, Keio Innovation Initiative, 1stRound.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Fermecutes
- ·The full record, as it builds
Funding rounds
No funding rounds for Fermecutes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fermecutes
Developer of sustainable protein alternatives intended to use natto bacteria to address global food scarcity issues. The company's focus is on creating a space-efficient protein source through fermentation to reduce reliance on traditional meat production and contribute to an environmentally friendly food system, providing people with services that will contribute to solving food problems.
- Sector
- Healthcare
- HQ
- Tsuruoka, Japan
- Founded
- 2021
- Website
- fermecutes.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Fermecutes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fermecutes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fermecutes in its N-PORT filings yet. We sweep new filings monthly.